HMPL-004: Phase III started

Nutrition Science Partners began the 2-part, international Phase III NATRUL-4 trial to evaluate 600 mg oral HMPL-004 thrice daily for an 8-week, open-label phase followed

Read the full 254 word article

User Sign In